Two new TB vaccines show safety but limited protection
Two new vaccines to prevent tuberculosis (TB) are safe for use in adults and children, but they do…
Evolocumab trial could reshape how doctors treat high-risk cholesterol patients
A major cholesterol guideline arrived just as pivotal new trial data emerged, revealing how fast-moving evidence could soon…
Psychiatrists’ use of biomarkers could open a new window into mental health diagnoses
Amanda Miller was 30 and pregnant with her second child in Hershey, Pennsylvania, when she developed depression. After…
High-dose vitamin D3 does not reduce COVID-19 severity, but may impact long COVID outcomes
In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not…
Chronic back pain linked to heightened sound sensitivity in the brain
People with chronic back pain process everyday sounds differently, and more intensely, than people without pain, according to…
Low‑dose oral lithium may help slow the decline of verbal memory, trial suggests
Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization. An exploratory clinical trial from…
Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
Short-duration psychedelic therapy shows promise for major depression treatment
A controlled clinical trial suggests a fast-acting psychedelic approach may reduce depressive symptoms, but researchers stress careful interpretation…
Psychedelic effects of ketamine do not predict sobriety
The psychedelic effects recreational users often seek from taking ketamine do not predict the therapeutic benefits for people…
Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation
New clinical trial evidence suggests targeting both obesity and sleep-disordered breathing together may reshape cardiometabolic risk management in…
Novel neuroprotective drug improves recovery after acute ischemic stroke
Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48…
Ashwagandha aids recovery without blunting training stress in athletes
A controlled trial in team-sport athletes suggests Ashwagandha may help maintain hormonal balance and support recovery and power…